{
    "clinical_study": {
        "@rank": "100735", 
        "arm_group": [
            {
                "arm_group_label": "Synbiotic", 
                "arm_group_type": "Active Comparator", 
                "description": "2 synbiotic capsules for 28 weeks"
            }, 
            {
                "arm_group_label": "maltodexterin", 
                "arm_group_type": "Placebo Comparator", 
                "description": "two capsules per day for 28 weeks"
            }
        ], 
        "brief_summary": {
            "textblock": "To study the effects of synbiotics supplement on lipid profile, liver enzymes, inflammatory\n      factors and hepatic fibrosis in patients with Nonalcoholic Steatohepatitis (NASH), 50\n      patients who referred to Gastrointestinal (GI) clinic with steatosis grade 1 or more will be\n      randomly allocated to receive 2 protexin capsules or placebos for 7 months; both groups will\n      be advised to adherence our diet and exercise program too. At the first and the end of the\n      intervention, lipid profiles, liver enzymes, some inflammatory cytokines, and liver fibrosis\n      will be assessed and compared between groups."
        }, 
        "brief_title": "The Effects of Synbiotics Supplement on Biochemical Factors and Hepatic Fibrosis in Patients With Nonalcoholic Steatohepatitis", 
        "completion_date": {
            "#text": "January 2013", 
            "@type": "Actual"
        }, 
        "condition": "Non Alcoholic Steatohepatitis", 
        "condition_browse": {
            "mesh_term": [
                "Fibrosis", 
                "Fatty Liver"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Age of 18 to 70 years\n\n          -  Body Mass Index (BMI) between 25-40\n\n          -  Serum alaninaminotransferase more than 1.5 fold of upper limit of normal range\n\n          -  Sonographic findings compatible with hepatic steatosis (degree 2 or more)\n\n        Exclusion Criteria:\n\n          -  Diabetes\n\n          -  Taking any kind of antibiotics two weeks before recruitment\n\n          -  History of alcohol consumption\n\n          -  pregnancy or lactation\n\n          -  Professional athletes\n\n          -  Other liver disease (viral/etc)\n\n          -  Use of drugs such as calcium channel blockers, high dose synthetic estrogens,\n             methotrexate , amiodarone, steroids, chloroquine, immunosuppressive drugs,\n             lipid-lowering agents, metformin and vitamin E\n\n          -  A history of Hypertension, Cardiovascular disease, Pulmonary disease, Renal disease &\n             Celiac disease; Cirrhosis\n\n          -  History of Upper GI surgery / Prior surgical procedures such as jejunoileal or\n             jejunocolic bypass, gastroplasty\n\n          -  Following program to lose weight in recent 3 mo\n\n          -  A history of hypothyroidism or Cushing's syndrome"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "70 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "54", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "February 5, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01791959", 
            "org_study_id": "046466"
        }, 
        "intervention": [
            {
                "arm_group_label": "Synbiotic", 
                "description": "2 symbiotics capsules per day for 28 weeks", 
                "intervention_name": "synbiotic", 
                "intervention_type": "Dietary Supplement"
            }, 
            {
                "arm_group_label": "maltodexterin", 
                "description": "2 Maltodexterin capsules  as a placebo per day for 28 weeks", 
                "intervention_name": "placebo", 
                "intervention_type": "Other"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "February 12, 2013", 
        "number_of_arms": "2", 
        "official_title": "The Effects of Synbiotics Supplement on Lipid Profile, Liver Enzymes, Inflammatory Factors and Hepatic Fibrosis in Patients With Nonalcoholic Steatohepatitis", 
        "overall_official": {
            "affiliation": "National Nutrition and Food Technology Research Institute", 
            "last_name": "Azita Hekmatdoost, MD, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "IRAN: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 2/Phase 3", 
        "primary_completion_date": {
            "#text": "October 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": [
            {
                "measure": "Alaninaminotransferase  (ALT)", 
                "safety_issue": "Yes", 
                "time_frame": "28 weeks"
            }, 
            {
                "measure": "Liver fibrosis", 
                "safety_issue": "No", 
                "time_frame": "28 weeks"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01791959"
        }, 
        "responsible_party": {
            "investigator_affiliation": "National Nutrition and Food Technology Institute", 
            "investigator_full_name": "Dr Azita Hekmatdoost", 
            "investigator_title": "Principal Investigator", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "Body Mass Index (BMI)", 
            "safety_issue": "No", 
            "time_frame": "28 weeks"
        }, 
        "source": "National Nutrition and Food Technology Institute", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "National Nutrition and Food Technology Institute", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "February 2013"
    }
}